Home » Prices » NASDAQ:MRNA

Moderna, Inc. stock price

Today's NASDAQ:MRNA chart, history & news

Price:
109.18 USD
Change:
+10.62 (10.78%)
Key Stats
Price open 99.2
Previous close 98.56
Market cap 43.20B
Volume 25.85M
Day high 109.29
Day low 98.65
Year high 109.29
Year low 17.68
Year to date change 478.53%
P/E Ratio -67.31
Company Profile
Fundamentals
Insider Information
News

About Moderna, Inc.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company information

Company name
Moderna, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
830
CEO
Stéphane Bancel
Address
200 Technology Square, Cambridge, MA, 02139
Country
United States
Contact information
1.617.714.6500
Website
http://www.modernatx.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.